Abstract

Among the promising non pharmacologic therapies for the management of heart failure are the implantable defibrillators and biventricular pacemakers. In the companion trial, cardiac resynchronization therapy with a pacemaker combined with an implantable defibrillator significantly decreased the likelihood of death from or hospitalization for heart failure when compared with conventional pharmacologic therapy.